Abstract

Greater exposure to estrogens is a risk factor for ovarian cancer. To investigate the role of estrogens in ovarian cancer, a spot urine sample and a saliva sample were obtained from 33 women with ovarian cancer and 34 age-matched controls. Thirty-eight estrogen metabolites, conjugates and DNA adducts were analyzed in the urine samples using ultraperformance liquid chromatography/ tandem mass spectrometry, and the ratio of adducts to metabolites and conjugates was calculated for each sample. The ratio of depurinating estrogen-DNA adducts to estrogen metabolites and conjugates was significantly higher in cases compared to controls (p < 0.0001), demonstrating high specificity and sensitivity. DNA was purified from the saliva samples and analyzed for genetic polymorphisms in the genes for two estrogen-metabolizing enzymes. Women with two low-activity alleles of catechol-O-methyltransferase plus one or two high-activity alleles of cytochrome P450 1B1 had higher levels of estrogen-DNA adducts and were more likely to have ovarian cancer. These findings indicate that estrogen metabolism is unbalanced in ovarian cancer and suggest that formation of estrogen-DNA adducts plays a critical role in the initiation of ovarian cancer.

Original languageEnglish (US)
Pages (from-to)2414-2423
Number of pages10
JournalInternational Journal of Cancer
Volume134
Issue number10
DOIs
StatePublished - May 15 2014

Fingerprint

Ovarian Neoplasms
Estrogens
DNA Adducts
Saliva
Alleles
Urine
Catechol O-Methyltransferase
Genetic Polymorphisms
Tandem Mass Spectrometry
Liquid Chromatography
Cytochrome P-450 Enzyme System
Sensitivity and Specificity
DNA
Enzymes
Genes

Keywords

  • CYP1B1
  • SNPs
  • catechol-O-methyltransferase
  • estrogen-DNA adducts
  • ovarian cancer
  • unbalanced estrogen metabolism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Unbalanced estrogen metabolism in ovarian cancer. / Zahid, Muhammad; Beseler, Cheryl L.; Hall, James B.; LeVan, Tricia D; Cavalieri, Ercole; Rogan, Eleanor G.

In: International Journal of Cancer, Vol. 134, No. 10, 15.05.2014, p. 2414-2423.

Research output: Contribution to journalArticle

@article{c74ecc02940947abb28f59c474292ef4,
title = "Unbalanced estrogen metabolism in ovarian cancer",
abstract = "Greater exposure to estrogens is a risk factor for ovarian cancer. To investigate the role of estrogens in ovarian cancer, a spot urine sample and a saliva sample were obtained from 33 women with ovarian cancer and 34 age-matched controls. Thirty-eight estrogen metabolites, conjugates and DNA adducts were analyzed in the urine samples using ultraperformance liquid chromatography/ tandem mass spectrometry, and the ratio of adducts to metabolites and conjugates was calculated for each sample. The ratio of depurinating estrogen-DNA adducts to estrogen metabolites and conjugates was significantly higher in cases compared to controls (p < 0.0001), demonstrating high specificity and sensitivity. DNA was purified from the saliva samples and analyzed for genetic polymorphisms in the genes for two estrogen-metabolizing enzymes. Women with two low-activity alleles of catechol-O-methyltransferase plus one or two high-activity alleles of cytochrome P450 1B1 had higher levels of estrogen-DNA adducts and were more likely to have ovarian cancer. These findings indicate that estrogen metabolism is unbalanced in ovarian cancer and suggest that formation of estrogen-DNA adducts plays a critical role in the initiation of ovarian cancer.",
keywords = "CYP1B1, SNPs, catechol-O-methyltransferase, estrogen-DNA adducts, ovarian cancer, unbalanced estrogen metabolism",
author = "Muhammad Zahid and Beseler, {Cheryl L.} and Hall, {James B.} and LeVan, {Tricia D} and Ercole Cavalieri and Rogan, {Eleanor G}",
year = "2014",
month = "5",
day = "15",
doi = "10.1002/ijc.28565",
language = "English (US)",
volume = "134",
pages = "2414--2423",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Unbalanced estrogen metabolism in ovarian cancer

AU - Zahid, Muhammad

AU - Beseler, Cheryl L.

AU - Hall, James B.

AU - LeVan, Tricia D

AU - Cavalieri, Ercole

AU - Rogan, Eleanor G

PY - 2014/5/15

Y1 - 2014/5/15

N2 - Greater exposure to estrogens is a risk factor for ovarian cancer. To investigate the role of estrogens in ovarian cancer, a spot urine sample and a saliva sample were obtained from 33 women with ovarian cancer and 34 age-matched controls. Thirty-eight estrogen metabolites, conjugates and DNA adducts were analyzed in the urine samples using ultraperformance liquid chromatography/ tandem mass spectrometry, and the ratio of adducts to metabolites and conjugates was calculated for each sample. The ratio of depurinating estrogen-DNA adducts to estrogen metabolites and conjugates was significantly higher in cases compared to controls (p < 0.0001), demonstrating high specificity and sensitivity. DNA was purified from the saliva samples and analyzed for genetic polymorphisms in the genes for two estrogen-metabolizing enzymes. Women with two low-activity alleles of catechol-O-methyltransferase plus one or two high-activity alleles of cytochrome P450 1B1 had higher levels of estrogen-DNA adducts and were more likely to have ovarian cancer. These findings indicate that estrogen metabolism is unbalanced in ovarian cancer and suggest that formation of estrogen-DNA adducts plays a critical role in the initiation of ovarian cancer.

AB - Greater exposure to estrogens is a risk factor for ovarian cancer. To investigate the role of estrogens in ovarian cancer, a spot urine sample and a saliva sample were obtained from 33 women with ovarian cancer and 34 age-matched controls. Thirty-eight estrogen metabolites, conjugates and DNA adducts were analyzed in the urine samples using ultraperformance liquid chromatography/ tandem mass spectrometry, and the ratio of adducts to metabolites and conjugates was calculated for each sample. The ratio of depurinating estrogen-DNA adducts to estrogen metabolites and conjugates was significantly higher in cases compared to controls (p < 0.0001), demonstrating high specificity and sensitivity. DNA was purified from the saliva samples and analyzed for genetic polymorphisms in the genes for two estrogen-metabolizing enzymes. Women with two low-activity alleles of catechol-O-methyltransferase plus one or two high-activity alleles of cytochrome P450 1B1 had higher levels of estrogen-DNA adducts and were more likely to have ovarian cancer. These findings indicate that estrogen metabolism is unbalanced in ovarian cancer and suggest that formation of estrogen-DNA adducts plays a critical role in the initiation of ovarian cancer.

KW - CYP1B1

KW - SNPs

KW - catechol-O-methyltransferase

KW - estrogen-DNA adducts

KW - ovarian cancer

KW - unbalanced estrogen metabolism

UR - http://www.scopus.com/inward/record.url?scp=84895925640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895925640&partnerID=8YFLogxK

U2 - 10.1002/ijc.28565

DO - 10.1002/ijc.28565

M3 - Article

C2 - 24170413

AN - SCOPUS:84895925640

VL - 134

SP - 2414

EP - 2423

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 10

ER -